Literature DB >> 22768800

Development and validation of the Mandarin disyllable recognition test.

Meimei Zhu1, Xiaosong Wang, Qian-Jie Fu.   

Abstract

CONCLUSION: Given the phonetic balancing across lists and the validation with spectrally degraded speech, the present Mandarin disyllable recognition test (DRT) materials may be useful for assessing speech performance of Mandarin-speaking cochlear implant (CI) users. If combined with the previously developed sentence materials, these materials would help to establish standardized speech perception tests for Mandarin-speaking hearing-impaired (HI) and CI patients.
OBJECTIVES: To develop standardized Mandarin DRT materials that can be used to evaluate the speech performance of Mandarin-speaking HI and CI patients, and to establish standardized Mandarin speech perception test materials that include both disyllables and sentences.
METHODS: Ten phonetically balanced Mandarin DRT lists were developed. The DRT materials were validated in 8 normal-hearing (NH) subjects listening to unprocessed speech and in 10 NH subjects listening to a 4-channel, sine-wave vocoded acoustic simulation of CI speech processing. Performance with the DRT materials was compared to that with Mandarin sentence materials previously developed by our group.
RESULTS: The distribution of vowels, consonants, and tones within each DRT list was similar to that observed across commonly used Chinese characters. There was no significant difference in disyllable word recognition across lists in both unprocessed and four-channel vocoded speech. There was a significant correlation between disyllable and sentence recognition performance.

Entities:  

Mesh:

Year:  2012        PMID: 22768800      PMCID: PMC5847333          DOI: 10.3109/00016489.2011.653668

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  15 in total

1.  Voice gender identification by cochlear implant users: the role of spectral and temporal resolution.

Authors:  Qian-Jie Fu; Sherol Chinchilla; Geraldine Nogaki; John J Galvin
Journal:  J Acoust Soc Am       Date:  2005-09       Impact factor: 1.840

2.  Psychometrically equivalent trisyllabic words for speech reception threshold testing in Mandarin.

Authors:  Shawn L Nissen; Richard W Harris; Lara-Jill Jennings; Dennis L Eggett; Holly Buck
Journal:  Int J Audiol       Date:  2005-07       Impact factor: 2.117

3.  Psychometrically equivalent Mandarin bisyllabic speech discrimination materials spoken by male and female talkers.

Authors:  Shawn L Nissen; Richard W Harris; Lara-Jill Jennings; Dennis L Eggett; Holly Buck
Journal:  Int J Audiol       Date:  2005-07       Impact factor: 2.117

4.  Development and evaluation of Mandarin disyllabic materials for speech audiometry in China.

Authors:  Shuo Wang; Robert Mannell; Philip Newall; Hua Zhang; Demin Han
Journal:  Int J Audiol       Date:  2007-12       Impact factor: 2.117

5.  Development of a mandarin monosyllable recognition test.

Authors:  Kuen-Shian Tsai; Li-Hui Tseng; Cheng-Jung Wu; Shuenn-Tsong Young
Journal:  Ear Hear       Date:  2009-02       Impact factor: 3.570

6.  Development of Mandarin monosyllabic speech test materials in China.

Authors:  Demin Han; Shuo Wang; Hua Zhang; Jing Chen; Wenbo Jiang; Robert Mannell; Philip Newall; Luo Zhang
Journal:  Int J Audiol       Date:  2009-05       Impact factor: 2.117

7.  The development of psychometrically equivalent Cantonese speech audiometry materials.

Authors:  Shawn L Nissen; Richard W Harris; Ron W Channell; Brooke Conklin; Misty Kim; Lena Wong
Journal:  Int J Audiol       Date:  2011-03       Impact factor: 2.117

8.  Speech discrimination scores of postlingually deaf adults implanted with the Combi 40 cochlear implant.

Authors:  W K Gstoettner; J Hamzavi; W D Baumgartner
Journal:  Acta Otolaryngol       Date:  1998-09       Impact factor: 1.494

9.  The development of Cantonese Lexical Neighborhood Test: a pilot study.

Authors:  Kevin C-P Yuen; Iris H-Y Ng; Betty P-K Luk; Sarah K-W Chan; Sabina C-S Chan; Irene C-L Kwok; Hip-Cho Yu; Tina M-Y Chan; Terry C-W Hung; Michael C-F Tong
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2008-05-15       Impact factor: 1.675

10.  Speech perception of Mandarin Chinese speaking young children after cochlear implant use: effect of age at implantation.

Authors:  Jiunn Liang Wu; Hui Mei Yang
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2003-03       Impact factor: 1.675

View more
  6 in total

1.  Validation of list equivalency for Mandarin speech materials to use with cochlear implant listeners.

Authors:  Yongxin Li; Shuncheng Wang; Qiaodang Su; John J Galvin; Qian-Jie Fu
Journal:  Int J Audiol       Date:  2016-07-14       Impact factor: 2.117

Review 2.  Auditory implant research at the House Ear Institute 1989-2013.

Authors:  Robert V Shannon
Journal:  Hear Res       Date:  2014-11-17       Impact factor: 3.208

3.  Contribution of auditory working memory to speech understanding in mandarin-speaking cochlear implant users.

Authors:  Duoduo Tao; Rui Deng; Ye Jiang; John J Galvin; Qian-Jie Fu; Bing Chen
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

4.  The Benefits of Residual Hair Cell Function for Speech and Music Perception in Pediatric Bimodal Cochlear Implant Listeners.

Authors:  Xiaoting Cheng; Yangwenyi Liu; Bing Wang; Yasheng Yuan; John J Galvin; Qian-Jie Fu; Yilai Shu; Bing Chen
Journal:  Neural Plast       Date:  2018-04-15       Impact factor: 3.599

5.  Bilaterally Combined Electric and Acoustic Hearing in Mandarin-Speaking Listeners: The Population With Poor Residual Hearing.

Authors:  Duo-Duo Tao; Ji-Sheng Liu; Zhen-Dong Yang; Blake S Wilson; Ning Zhou
Journal:  Trends Hear       Date:  2018 Jan-Dec       Impact factor: 3.293

6.  Music Training Can Improve Music and Speech Perception in Pediatric Mandarin-Speaking Cochlear Implant Users.

Authors:  Xiaoting Cheng; Yangwenyi Liu; Yilai Shu; Duo-Duo Tao; Bing Wang; Yasheng Yuan; John J Galvin; Qian-Jie Fu; Bing Chen
Journal:  Trends Hear       Date:  2018 Jan-Dec       Impact factor: 3.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.